HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 4.160
+0.140 (3.48%)
May 7, 2026, 4:08 PM HKT
HighTide Therapeutics Employees
HighTide Therapeutics had 57 employees as of June 30, 2025. The number of employees decreased by 13 or -18.57% since the number was reported on December 31, 2024.
Employees
57
Change
-13
Growth
-18.57%
Revenue / Employee
n/a
Profits / Employee
-5.35M HKD
Market Cap
2.38B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 57 | -13 | -18.57% |
| Dec 31, 2024 | 70 | 4 | 6.06% |
| Dec 31, 2023 | 66 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,794 |
| Frontage Holdings | 1,523 |
| AIM Vaccine | 1,466 |
| Jiangsu Recbio Technology | 491 |
| Mabpharm | 383 |
| Cutia Therapeutics | 304 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 202 |
| Beijing Biostar Pharmaceuticals | 131 |